High PD-L1 expression predicts poor prognosis in diffuse large B-cell lymphoma

被引：6
|
作者：
Cheng, Zhiheng [1 ,2 ,3 ]
Dai, Yifeng [4 ]
Wang, Jing [1 ,2 ]
Shi, Jinlong [3 ,5 ,6 ]
Ke, Xiaoyan [1 ,2 ]
Fu, Lin [1 ,2 ]
机构：
[1] Peking Univ, Hosp 3, Dept Hematol, Beijing 100191, Peoples R China
[2] Peking Univ, Hosp 3, Lymphoma Res Ctr, Beijing 100191, Peoples R China
[3] Henan Univ, Translat Med Ctr, Huaihe Hosp, Kaifeng 475000, Peoples R China
[4] Shantou Univ, Lab Environm Med & Dev Toxicol, Coll Med, Shantou 515041, Peoples R China
[5] Chinese Peoples Liberat Army Gen Hosp, Dept Biomed Engn, Beijing 100853, Peoples R China
[6] Chinese Peoples Liberat Army Gen Hosp, Dept Med Big Data, Beijing 100853, Peoples R China
来源：
ANNALS OF HEMATOLOGY | 2018年 / 97卷 / 06期
基金：
中国国家自然科学基金;
关键词：
DEATH LIGAND 1; CANCER; INHIBITION; ACTIVATION; SURVIVAL; FOXO1;
D O I：
10.1007/s00277-018-3266-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1085 / 1088
页数：4
相关论文
共 50 条
  • [31] Overexpression of GLT1D1 induces immunosuppression through glycosylation of PD-L1 and predicts poor prognosis in B-cell lymphoma
    Liu, Xiaoxia
    Zhang, Yanyu
    Han, Yi
    Lu, Wenhua
    Yang, Jing
    Tian, Jingyu
    Sun, Peng
    Yu, Tiantian
    Hu, Yumin
    Zhang, Hui
    Huang, Peng
    Liu, Panpan
    MOLECULAR ONCOLOGY, 2020, 14 (05) : 1028 - 1044
  • [32] Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells
    Dong, Ling
    Lv, Huijuan
    Li, Wei
    Song, Zheng
    Li, Lanfang
    Zhou, Shiyong
    Qiu, Lihua
    Qian, Zhengzi
    Liu, Xianming
    Feng, Lixia
    Meng, Bin
    Fu, Kai
    Wang, Xi
    Pan-Hammarstrom, Qiang
    Wang, Ping
    Wang, Xianhuo
    Zhang, Huilai
    ONCOTARGET, 2016, 7 (22) : 33350 - 33362
  • [33] Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells
    Zhang, H.
    Wang, X.
    Dong, L.
    Lv, H.
    Li, W.
    Song, Z.
    Li, L.
    Zhou, S.
    Qiu, L.
    Qian, Z.
    Liu, X.
    Feng, L.
    Meng, B.
    Fu, K.
    Wang, X.
    Pan-Hammarstrom, Q.
    Wang, P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [34] The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma: a meta-analysis
    Qiu, Liping
    Zheng, Hanlu
    Zhao, Xiaoying
    BMC CANCER, 2019, 19 (1)
  • [35] PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications
    Xing, Wei
    Dresser, Karen
    Zhang, Rui
    Evens, Andrew M.
    Yu, Hongbo
    Woda, Bruce A.
    Chen, Benjamin J.
    ONCOTARGET, 2016, 7 (37) : 59976 - 59986
  • [36] The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma: a meta-analysis
    Liping Qiu
    Hanlu Zheng
    Xiaoying Zhao
    BMC Cancer, 19
  • [37] Low Expression of the CIITA Gene Predicts Poor Outcome in Diffuse Large B-Cell Lymphoma
    Autio, Matias
    Jantti, Kirsi
    Cervera, Alejandra
    Hautaniemi, Sampsa
    Leppa, Sirpa
    BLOOD, 2016, 128 (22)
  • [38] MYC protein expression is associated with poor prognosis in cutaneous diffuse large B-cell lymphoma
    Kim, Young Jae
    Won, Chong Hyun
    Chang, Sung Eun
    Choi, Jee Ho
    Lee, Mi Woo
    Lee, Woo Jin
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 (03) : E240 - E242
  • [39] High tumoral PD-L1 expression and low PD-1+ or CD8+ tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system
    Kim, Sehui
    Nam, Soo Jeong
    Park, Changhee
    Kwon, Dohee
    Yim, Jeemin
    Song, Seung Geun
    Ock, Chan-Young
    Kim, Young A.
    Park, Sung Hye
    Kim, Tae Min
    Jeon, Yoon Kyung
    ONCOIMMUNOLOGY, 2019, 8 (09):
  • [40] Programmed death-ligand 1 expression in diffuse large B-cell lymphoma is associated with poor prognosis
    Sughayer, M.
    Abbas, M.
    Al-Khateeb, E.
    Khader, M.
    HISTOPATHOLOGY, 2022, 81 : 101 - 102
12345